Segui
Luisa Guidi
Titolo
Citata da
Citata da
Anno
Advanced age is an independent risk factor for severe infections and mortality in patients given anti–tumor necrosis factor therapy for inflammatory bowel disease
M Cottone, A Kohn, M Daperno, A Armuzzi, L Guidi, R D'Inca, F Bossa, ...
Clinical Gastroenterology and Hepatology 9 (1), 30-35, 2011
3732011
The effect of zinc and vitamin A supplementation on immune response in an older population
C Fortes, F Forastiere, N Agabiti, V Fano, R Pacifici, F Virgili, G Piras, ...
Journal of the American Geriatrics Society 46 (1), 19-26, 1998
2001998
Paroxetine and fluoxetine effects on mood and cognitive functions in depressed nondemented elderly patients
GB Cassano, F Puca, PL Scapicchio, M Trabucchi, ...
Journal of Clinical Psychiatry 63 (5), 396-402, 2002
1672002
Dermatological adverse reactions during anti-TNF treatments: focus on inflammatory bowel disease
G Mocci, M Marzo, A Papa, A Armuzzi, L Guidi
Journal of Crohn's and Colitis 7 (10), 769-779, 2013
1562013
The PROSIT-BIO cohort: a prospective observational study of patients with inflammatory bowel disease treated with infliximab biosimilar
G Fiorino, N Manetti, A Armuzzi, A Orlando, A Variola, S Bonovas, ...
Inflammatory bowel diseases 23 (2), 233-243, 2017
1482017
Management of perianal fistulas in Crohn’s disease: an up-to-date review
M Marzo, C Felice, D Pugliese, G Andrisani, G Mocci, A Armuzzi, L Guidi
World Journal of Gastroenterology: WJG 21 (5), 1394, 2015
1382015
Paradoxical psoriasis in a large cohort of patients with inflammatory bowel disease receiving treatment with anti‐TNF alpha: 5‐year follow‐up study
D Pugliese, L Guidi, PM Ferraro, M Marzo, C Felice, L Celleno, R Landi, ...
Alimentary pharmacology & therapeutics 42 (7), 880-888, 2015
1102015
Early atherosclerosis in patients with inflammatory bowel disease
A Papa, S Danese, R Urgesi, A Grillo, S Guglielmo, I Roberto, M Bonizzi, ...
European review for medical and pharmacological sciences 10 (1), 7, 2006
1082006
Prevention of postoperative recurrence with azathioprine or infliximab in patients with Crohn's disease: an open-label pilot study
A Armuzzi, C Felice, A Papa, M Marzo, D Pugliese, G Andrisani, ...
Journal of Crohn's and Colitis 7 (12), e623-e629, 2013
1062013
Immune response to influenza A/H1N1 vaccine in inflammatory bowel disease patients treated with anti TNF-α agents: effects of combined therapy with immunosuppressants
G Andrisani, D Frasca, M Romero, A Armuzzi, C Felice, M Marzo, ...
Journal of Crohn's and Colitis 7 (4), 301-307, 2013
1062013
Ileal Crohn disease: mural microvascularity quantified with contrast-enhanced US correlates with disease activity
A De Franco, A Di Veronica, A Armuzzi, I Roberto, M Marzo, ...
Radiology 262 (2), 680-688, 2012
1022012
Increased carotid intima–media thickness in patients with inflammatory bowel disease
A Papa, A Santoliquido, S Danese, M Covino, CD Campli, R Urgesi, ...
Alimentary pharmacology & therapeutics 22 (9), 839-846, 2005
1002005
Infliximab in steroid-dependent ulcerative colitis: effectiveness and predictors of clinical and endoscopic remission
A Armuzzi, D Pugliese, S Danese, G Rizzo, C Felice, M Marzo, ...
Inflammatory bowel diseases 19 (5), 1065-1072, 2013
992013
Anti TNF-α therapy for ulcerative colitis: current status and prospects for the future
D Pugliese, C Felice, A Papa, A Gasbarrini, GL Rapaccini, L Guidi, ...
Expert Review of Clinical Immunology 13 (3), 223-233, 2017
952017
Functional type 1 regulatory T cells develop regardless of FOXP3 mutations in patients with IPEX syndrome
L Passerini, S Di Nunzio, S Gregori, E Gambineri, M Cecconi, MG Seidel, ...
European journal of immunology 41 (4), 1120-1131, 2011
952011
Long-term combination therapy with infliximab plus azathioprine predicts sustained steroid-free clinical benefit in steroid-dependent ulcerative colitis
A Armuzzi, D Pugliese, S Danese, G Rizzo, C Felice, M Marzo, ...
Inflammatory bowel diseases 20 (8), 1368-1374, 2014
892014
Adalimumab in active ulcerative colitis: a “real-life” observational study
A Armuzzi, L Biancone, M Daperno, A Coli, D Pugliese, V Annese, ...
Digestive and Liver Disease 45 (9), 738-743, 2013
882013
Prevalence and natural history of hepatitis B and C infections in a large population of IBD patients treated with anti-tumor necrosis factor-α agents
A Papa, C Felice, M Marzo, G Andrisani, A Armuzzi, M Covino, G Mocci, ...
Journal of Crohn's and Colitis 7 (2), 113-119, 2013
862013
Faecal calprotectin assay after induction with anti-Tumour Necrosis Factor α agents in inflammatory bowel disease: Prediction of clinical response and mucosal healing at one year
L Guidi, M Marzo, G Andrisani, C Felice, D Pugliese, G Mocci, O Nardone, ...
Digestive and Liver Disease 46 (11), 974-979, 2014
852014
Harmful effects and potential benefits of anti-tumor necrosis factor (TNF)-α on the liver
LR Lopetuso, G Mocci, M Marzo, F D’Aversa, GL Rapaccini, L Guidi, ...
International journal of molecular sciences 19 (8), 2199, 2018
842018
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20